导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.53% | 711/1050 |
| 近一周 | -4.89% | 1075/1104 |
| 近一月 | 2.64% | 28/1103 |
| 近一季 | 4.01% | 165/1092 |
| 近半年 | -13.36% | 866/1070 |
| 近一年 | -6.04% | 674/1018 |
| 近两年 | 26.50% | 719/926 |
| 近三年 | 3.48% | 643/834 |
| 成立以来 | 17.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.83% 266/1070 |
-14.59% 1013/1101 |
- - |
- - |
| 2025 | 13.61% 779/1065 |
-1.50% 879/1014 |
5.66% 262/1038 |
7.52% 889/1050 |
1.53% 345/1065 |
| 2024 | -7.99% 744/1011 |
-3.75% 525/960 |
-5.94% 687/983 |
4.36% 901/991 |
-2.61% 498/1011 |
| 2023 | -6.02% 225/952 |
2.32% 489/880 |
-7.52% 666/895 |
-4.60% 277/915 |
4.11% 31/952 |
| 2022 | -23.42% 449/867 |
-19.45% 489/773 |
9.52% 286/806 |
-11.58% 356/845 |
-1.82% 529/867 |
| 2021 | 5.70% 291/740 |
0.45% 134/580 |
9.86% 361/659 |
-9.45% 496/704 |
5.78% 193/740 |
| 2020 | 74.25% 121/554 |
8.50% 47/419 |
23.01% 226/466 |
17.24% 95/517 |
11.36% 316/554 |
| 2019 | 50.89% 142/410 |
34.12% 172/1149 |
-1.62% 493/1231 |
7.03% 161/390 |
6.84% 282/410 |
| 2018 | -20.78% 93/349 |
- - |
- - |
- - |
-13.04% 737/1080 |
| 2017 | 13.88% 119/285 |
- - |
- - |
- - |
- - |
| 2016 | -18.55% 109/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 工银农业产业股票 VS. 东吴新产业精选股票A(580008) |